Revista española de salud pública
-
The impact on health of alcohol in a given society is mainly related with the volume and pattern of drinking, and these are related with individual factors, but also with environmental factors, among which public policies are important determinants. Public policies may favour or reduce alcohol use, and thus have a substantial preventive capacity. ⋯ The regulation of alcohol promotion and publicity is also assessed, as well as the detection and treatment of alcohol abuse and dependence. The state of alcohol related policies in Spain is analysed, as well as the obstacles, for the adoption of policies more prone to prevention, and recommendations for the future are made.
-
Rev. Esp. Salud Publica · Jul 2009
Review[Professional dance: an appraisal from the occupational health].
Dance is essentially an artistic discipline, with the dancer being exposed, as in any other occupation, to occupational risk factors. This document aims at identifying the characteristics about Professional Dance and its impact on the dancer's health. ⋯ Scientific production gets us closer to the health condition of dance professionals, but doesn't provide an insight on the cause-effect relationship of this profession's pathologies because most studies are merely descriptive. These studies underline the need of a deeper research on nutrition training, its stand before lesions, social and working conditions, and the training of dedicated professionals on occupational health in professional dance.
-
Rev. Esp. Salud Publica · Nov 2006
Review[Aspirin for the primary prevention of cardiovascular diseases in diabetic patients. A review of currently available tests].
The benefits of aspirin treatment in reducing the risk of myocardial infarction, cerebrovascular accidents and vascular death is well-documented among individuals having prior cardiovascular disease, including the subgroup with diabetes mellitus. The role of aspirin in primary prevention is less clear and debatable: the results of the clinical trials currently available are not consistent, although the meta-analyses are favorable in some aspects. ⋯ Despite this fact, in 1997, the American Diabetes Association and more recently other scientific societies (including several Spanish societies) have been recommending the use of aspirin in low doses in primary prevention in all type 1 or type 2 diabetic patients over 40 years of age and in all those within the 21-40 age range having any other cardiovascular risk factor in addition to diabetes (family history of vascular disease, hypertension, smoking, dyslipidemia or albuminuria). This study reviews the findings of the randomized, controlled clinical trials on primary cardiovascular prevention with aspirin, on which the official American Diabetes Association guidelines might be based, the conclusion being reached that there is not currently sufficient scientific evidence to uphold these guidelines.